StockMarketWire.com - OptiBiotix Health said subsidiary ProBiotix Health had signed a license agreement with Nutrilinea for the use of the company's technology in a food supplement for the reduction of high blood pressure.

Nutrilinea would cover the cost of all product development, manufacturing and human studies in return for 12 months exclusivity for the European market.

ProBiotix had exclusivity for the UK and all other markets outside Europe.

Nutrilinea, based near Milan in northern Italy, was a manufacturer of food supplement formulations containing probiotics for the food and pharmaceutical industries in Europe and the US.




Story provided by StockMarketWire.com